Testing effectiveness (Phase 2)UnknownNCT05709171
What this trial is testing
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Who this might be right for
GEP-NETNeuroendocrine TumorsNeuroendocrine Carcinoma+1 more
Rigshospitalet, Denmark 200